CAS Medical Systems, Inc. (CASM) Analysts See $-0.08 EPS

April 20, 2018 - By Clifton Ray

CAS Medical Systems, Inc. (NASDAQ:CASM) LogoInvestors sentiment increased to 1 in Q4 2017. Its up 0.17, from 0.83 in 2017Q3. It increased, as 2 investors sold CAS Medical Systems, Inc. shares while 3 reduced holdings. 3 funds opened positions while 2 raised stakes. 6.42 million shares or 0.78% more from 6.37 million shares in 2017Q3 were reported.
Rmb Cap Lc invested in 20,000 shares or 0% of the stock. Td Cap Mngmt Ltd Liability Com stated it has 0.01% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Vanguard Grp Inc Incorporated holds 531,881 shares. 12,172 were accumulated by Guggenheim Cap Ltd Com. Citadel Advsrs Ltd Company reported 32,680 shares stake. California Employees Retirement reported 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Moreover, Northern Tru has 0% invested in CAS Medical Systems, Inc. (NASDAQ:CASM) for 25,101 shares. Two Sigma Securities Limited Com holds 0% in CAS Medical Systems, Inc. (NASDAQ:CASM) or 24,346 shares. Wells Fargo And Mn holds 0% or 227 shares in its portfolio. Renaissance Lc stated it has 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Royal Commercial Bank Of Canada holds 20 shares or 0% of its portfolio. Morgan Stanley reported 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Hightower Advisors Ltd Company has 0% invested in CAS Medical Systems, Inc. (NASDAQ:CASM). Penbrook Management Ltd Liability reported 0.02% in CAS Medical Systems, Inc. (NASDAQ:CASM). Acuta Cap Partners Ltd Liability holds 0.75% or 5.16M shares.

Since March 15, 2018, it had 0 buys, and 1 insider sale for $3,489 activity.

Analysts expect CAS Medical Systems, Inc. (NASDAQ:CASM) to report $-0.08 EPS on May, 2.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.08 EPS. After having $-0.07 EPS previously, CAS Medical Systems, Inc.’s analysts see 14.29 % EPS growth. The stock decreased 2.56% or $0.03 during the last trading session, reaching $1.14. About 38,853 shares traded or 80.75% up from the average. CAS Medical Systems, Inc. (NASDAQ:CASM) has declined 14.97% since April 20, 2017 and is downtrending. It has underperformed by 26.52% the S&P500.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $31.27 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

CAS Medical Systems, Inc. (NASDAQ:CASM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.